Double-blind study of Naproxen in osteoarthritis of the knee joint. 1976

S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima

To determine the effectiveness of naproxen in the treatment of osteoarthritis of the knee joint, a double-blind cross-over study against placebo was carried out on 61 patients. Statistically significant positive therapeutic effects were observed, including analgesia, increased mobility, decrease in joint swelling and improvement in activities of daily living. Side effects were infrequent, mild and disappeared rapidly.

UI MeSH Term Description Entries
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009068 Movement The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior. Movements
D009280 Naphthaleneacetic Acids Naphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc. Acids, Naphthaleneacetic
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1982, The Journal of international medical research,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1982, The Journal of international medical research,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1985, The Journal of international medical research,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1977, Journal of clinical pharmacology,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
October 1977, Therapeutische Umschau. Revue therapeutique,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1981, The British journal of clinical practice,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1973, Scandinavian journal of rheumatology. Supplement,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1995, Clinical therapeutics,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1987, Pharmatherapeutica,
S Tanaka, and T Ito, and E Mori, and T Muroga, and A Nakajima
January 1986, Clinical rheumatology,
Copied contents to your clipboard!